+$1.8M
Net Activity
Institutions Holding
62
Popularity Rank
#5500
Avg Weight
0.07%
Total Value
$34.6M
62 institutions currently hold NVCT, with 33 net buyers and 12 net sellers this quarter.
Institutional Moves (Q1 2026)
Majority Increased
Based on recent trading activity
Net Selling Institutions
12
Net Buying Institutions
33
Top 5 by Value
+$15.7M
Total Buy Value
$11.9M
Total Sell Value
33
Net Buyers
12
Net Sellers
No Form 144 planned sale filings in the last 90 days
No Schedule 13D/13G filings for this ticker
1
Filings (14d)
Nuvectis Pharma entered into an underwriting agreement to sell 5 million shares of common stock at $20 per share in a firm commitment public offering. The company expects to net about $93 million from the sale, or up to $107 million if the underwriters exercise an option to buy an additional 750,000 shares. The offering is set to close on July 1, 2026.
View Full Filing (SEC EDGAR)The most-added stocks by 13F institutions this quarter
Institutions Holding
6,150
Total reported value
$2.1T
3245 13F institutions increased their position this quarter
Institutions Holding
5,957
Total reported value
$1.5T
3028 13F institutions increased their position this quarter
Institutions Holding
5,764
Total reported value
$3.0T
2743 13F institutions increased their position this quarter